Delivery Order SPE2DB20D1100-SPE2DB24FD8U1

Award Date 9/17/24
Potential Completion Date 9/18/24
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of Lyrica 150 mg capsules. The contract has a ceiling value of $1,613.70 and is a firm fixed-price delivery order that does not have a set-aside designation. The contract has an ultimate completion date of September 13, 2024. AmerisourceBergen, as a major pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) by the DLA and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,491.29, is a Firm Fixed Price Delivery Order for the supply of Lyrica 150 mg Capsules. The contract has an ultimate completion date of September 25, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,911.60 firm fixed-price delivery order contract is for the provision of Lyrica 50 mg capsules. The contract has an ultimate completion date of February 3, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,821.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lyrica 150 mg capsules in 90-count packages. This is a firm fixed-price delivery order contract with a completion date of January 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,534.05 firm fixed-price delivery order is for the supply of Lyrica 300 mg capsules. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Lyrica 50mg capsules. The $1,326.06 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities, including pharmaceuticals, to support military treatment...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued up to $1,146.00, is for the delivery of Lyrica 150 mg capsules. This is a firm fixed price, delivery order contract with an ultimate completion date of October 1, 2024. The contract does not have a set-aside designation. Amerisourcebergen, a large pharmaceutical distributor, has been awarded...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $11,404.59, is for the delivery of Lyrica 150 mg capsules. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,070.81 firm fixed-price delivery order is for the supply of Lyrica 50 mg capsules. The contract has an ultimate completion date of February 18, 2025 and was awarded on February 14, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lyrica 100 mg capsules. The $9,410.47 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. This IDC with the DLA Troop Support...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD8U1
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Lyrica 150 mg capsules. The $3,227.40 firm-fixed-price contract has a completion date of September 18, 2024. AmerisourceBergen, a large pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies to supply a wide range of medical commodities, including prescription drugs, vaccines, and medical equipment. This specific award does not have a set-aside designation. The contract is part of DLA's broader efforts to ensure military treatment facilities and other government healthcare providers have access to essential pharmaceutical products to support the medical needs of military personnel, veterans, and other federal beneficiaries.

Generated 12/17/24, 9:10 AM